Summit Therapeutics PLC (NASDAQ:SMMT)

3.31
Delayed Data
As of Jul 02
 +0.13 / +4.09%
Today’s Change
1.18
Today|||52-Week Range
5.49
+106.88%
Year-to-Date
No recent news for Summit Therapeutics PLC.

Today’s Trading

Previous close3.18
Today’s open3.28
Day’s range3.28 - 3.31
Volume545
Average volume (3 months)181,451
Market cap$214.5M
Data as of 3:59pm ET, 07/02/2020

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+46.23%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales53.79
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc-0.04-1.47%
PRTKParatek Pharmaceutic...+0.04+0.78%
EVLOEvelo Biosciences In...+0.08+1.62%
GMDAGamida Cell Ltd-0.15-3.30%
Data as of 3:59pm ET, 07/02/2020

Financials

Last reporting date--
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$811.4K
Annual profit (last year)-$30.7M
Net profit margin-3,779.07%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Abingdon, Oxfordshire

Forecasts